Sepsis-3: Insights from the Lead Author

Raum-Typ

Permanent

Vorname

Dieses Feld ist erforderlich.

Nachname

Dieses Feld ist erforderlich.

E-Mail-Adresse

Dieses Feld ist erforderlich.

Unternehmen

Dieses Feld ist erforderlich.

Erforderliche Felder

Bezahlung per

Bevor Sie Ihr Ticket kaufen, prüfen Sie bitte hier die technischen Voraussetzungen für die Teilnahme an der Veranstaltung.

Wenn Sie sich bereits registriert haben und die Bestätigungsmail Ihrer Registrierung nicht finden können, klicken Sie bitte hier!

Systemkonfigurationstest. Hier klicken!

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Agenda

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.